Prostate cancer news

‘Nothing to lose and everything to gain’ – Alfred’s story

Read Alfred's story of joining the STAMPEDE clinical trial. His is one of the many stories featured in our 2016/17 Annual Review.

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

Blood test could help personalise treatment for advanced prostate cancer

Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer.

‘Once in a career feeling’ as trial shows offering prostate cancer drug earlier improves survival

We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer.

Giving prostate cancer drug earlier extends lives of men whose disease has spread

Offering abiraterone (Zytiga) up-front with standard hormone treatment extends survival in men whose prostate cancer has spread.

Pages